LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Book: Medical malpractice expert witnessing

    Hookman, Perry

    introductory guide for physicians and medical professionals

    2008  

    Author's details Perry Hookman
    Keywords Physicians/Malpractice ; Medical personnel/Malpractice ; Evidence, Expert
    Subject code 344.7304121
    Language English
    Size XXXIV, 552 S. : Ill., graph. Darst., 26cm
    Publisher CRC Press
    Publishing place Boca Raton, Fla
    Publishing country United States
    Document type Book
    Note Includes bibliographical references and index
    Accompanying material 1 CD-ROM (12 cm)
    HBZ-ID HT015274283
    ISBN 1-4200-5895-9 ; 978-1-4200-5895-6
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Victorian origins of William Osler's philosemitism?

    Hookman, Perry

    Proceedings (Baylor University. Medical Center)

    2011  Volume 24, Issue 4, Page(s) 320–323

    Language English
    Publishing date 2011-04-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2703932-8
    ISSN 1525-3252 ; 0899-8280
    ISSN (online) 1525-3252
    ISSN 0899-8280
    DOI 10.1080/08998280.2011.11928749
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Testifying as a medical expert witness, and why I like it.

    Hookman, Perry

    Physician executive

    2011  Volume 37, Issue 2, Page(s) 30–33

    MeSH term(s) Attitude of Health Personnel ; Expert Testimony/ethics ; Humans ; Malpractice/legislation & jurisprudence ; United States
    Language English
    Publishing date 2011-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1404480-8
    ISSN 0898-2759
    ISSN 0898-2759
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Medical malpractice expert witness

    Hookman, Perry

    introductory guide for physicians and medical professionals

    2008  

    Author's details Perry Hookman
    MeSH term(s) Expert Testimony/methods ; Physicians ; Malpractice
    Keywords United States
    Language English
    Size xxxiv, 552 p. +
    Publisher CRC ; Taylor & Francis distributor
    Publishing place Boca Raton, Fla ; London
    Document type Book
    Accompanying material 1 CD-ROM (4 3/4 in.)
    ISBN 9781420058956 ; 1420058959
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  5. Article ; Online: Clostridium difficile associated infection, diarrhea and colitis.

    Hookman, Perry / Barkin, Jamie S

    World journal of gastroenterology

    2009  Volume 15, Issue 13, Page(s) 1554–1580

    Abstract: A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, ...

    Abstract A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, which was infrequent prior to 2001. The name of this strain reflects its characteristics, demonstrated by different typing methods: pulsed-field gel electrophoresis (NAP1), restriction endonuclease analysis (BI) and polymerase chain reaction (027). In 2004 and 2005, the US Centers for Disease Control and Prevention (CDC) emphasized that the risk of C. difficile-associated diarrhea (CDAD) is increased, not only by the usual factors, including antibiotic exposure, but also gastrointestinal surgery/manipulation, prolonged length of stay in a healthcare setting, serious underlying illness, immune-compromising conditions, and aging. Patients on proton pump inhibitors (PPIs) have an elevated risk, as do peripartum women and heart transplant recipients. Before 2002, toxic megacolon in C. difficile-associated colitis (CDAC), was rare, but its incidence has increased dramatically. Up to two-thirds of hospitalized patients may be infected with C. difficile. Asymptomatic carriers admitted to healthcare facilities can transmit the organism to other susceptible patients, thereby becoming vectors. Fulminant colitis is reported more frequently during outbreaks of C. difficile infection in patients with inflammatory bowel disease (IBD). C. difficile infection with IBD carries a higher mortality than without underlying IBD. This article reviews the latest information on C. difficile infection, including presentation, vulnerable hosts and choice of antibiotics, alternative therapies, and probiotics and immunotherapy. We review contact precautions for patients with known or suspected C. difficile-associated disease. Healthcare institutions require accurate and rapid diagnosis for early detection of possible outbreaks, to initiate specific therapy and implement effective control measures. A comprehensive C. difficile infection control management rapid response team (RRT) is recommended for each health care facility. A communication network between RRTs is recommended, in coordination with each country's department of health. Our aim is to convey a comprehensive source of information and to guide healthcare professionals in the difficult decisions that they face when caring for these oftentimes very ill patients.
    MeSH term(s) Animals ; Bacterial Proteins/metabolism ; Bacterial Toxins/metabolism ; Clostridioides difficile/metabolism ; Clostridioides difficile/pathogenicity ; Clostridium Infections/complications ; Clostridium Infections/physiopathology ; Clostridium Infections/therapy ; Clostridium Infections/transmission ; Colitis/complications ; Colitis/etiology ; Colitis/physiopathology ; Comorbidity ; Diagnosis, Differential ; Diarrhea/etiology ; Diarrhea/physiopathology ; Disease Outbreaks/prevention & control ; Enterotoxins/metabolism ; Fluoroquinolones/therapeutic use ; Humans ; Inflammatory Bowel Diseases/complications ; Probiotics/therapeutic use ; Risk Factors
    Chemical Substances Bacterial Proteins ; Bacterial Toxins ; Enterotoxins ; Fluoroquinolones ; tcdA protein, Clostridium difficile ; toxB protein, Clostridium difficile
    Language English
    Publishing date 2009-04-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2185929-2
    ISSN 2219-2840 ; 1007-9327
    ISSN (online) 2219-2840
    ISSN 1007-9327
    DOI 10.3748/wjg.15.1554
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

    Hookman, Perry / Barkin, Jamie S

    Digestive diseases and sciences

    2007  Volume 52, Issue 4, Page(s) 1071–1075

    MeSH term(s) Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Bacterial Toxins/genetics ; Bacterial Toxins/metabolism ; Botulinum Toxins/metabolism ; Clostridium Infections/epidemiology ; Clostridium Infections/microbiology ; Clostridium difficile/genetics ; Clostridium difficile/pathogenicity ; Colitis/epidemiology ; Colitis/microbiology ; Cross Infection/epidemiology ; Cross Infection/microbiology ; Diarrhea/epidemiology ; Diarrhea/microbiology ; Disease Outbreaks/statistics & numerical data ; Drug Resistance, Bacterial ; Enterotoxins/genetics ; Enterotoxins/metabolism ; Humans ; Virulence
    Chemical Substances Bacterial Proteins ; Bacterial Toxins ; Enterotoxins ; tcdA protein, Clostridium difficile ; toxB protein, Clostridium difficile ; Botulinum Toxins (EC 3.4.24.69)
    Language English
    Publishing date 2007-04
    Publishing country United States
    Document type Comment ; Journal Article ; Review
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-006-9450-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Clostridium difficile associated infection, diarrhea and colitis

    Perry Hookman, Jamie S Barkin

    World Journal of Gastroenterology, Vol 15, Iss 13, Pp 1554-

    2009  Volume 1580

    Abstract: A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, ...

    Abstract A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, which was infrequent prior to 2001. The name of this strain reflects its characteristics, demonstrated by different typing methods: pulsed-field gel electrophoresis (NAP1), restriction endonuclease analysis (BI) and polymerase chain reaction (027). In 2004 and 2005, the US Centers for Disease Control and Prevention (CDC) emphasized that the risk of C. difficile-associated diarrhea (CDAD) is increased, not only by the usual factors, including antibiotic exposure, but also gastrointestinal surgery/manipulation, prolonged length of stay in a healthcare setting, serious underlying illness, immune-compromising conditions, and aging. Patients on proton pump inhibitors (PPIs) have an elevated risk, as do peripartum women and heart transplant recipients. Before 2002, toxic megacolon in C. difficile-associated colitis (CDAC), was rare, but its incidence has increased dramatically. Up to two-thirds of hospitalized patients may be infected with C. difficile. Asymptomatic carriers admitted to healthcare facilities can transmit the organism to other susceptible patients, thereby becoming vectors. Fulminant colitis is reported more frequently during outbreaks of C. difficile infection in patients with inflammatory bowel disease (IBD). C. difficile infection with IBD carries a higher mortality than without underlying IBD. This article reviews the latest information on C. difficile infection, including presentation, vulnerable hosts and choice of antibiotics, alternative therapies, and probiotics and immunotherapy. We review contact precautions for patients with known or suspected C. difficile-associated disease. Healthcare institutions require accurate and rapid diagnosis for early detection of possible outbreaks, to initiate specific therapy and implement effective control measures. A comprehensive C. difficile infection control management rapid response team (RRT) is recommended for each health care facility. A communication network between RRTs is recommended, in coordination with each country’s department of health. Our aim is to convey a comprehensive source of information and to guide healthcare professionals in the difficult decisions that they face when caring for these oftentimes very ill patients.
    Keywords Clostridium difficile ; Colitis ; Diarrhea ; Gastroenterology ; Nosocomial infection ; Iatrogenic infection ; Diseases of the digestive system. Gastroenterology ; RC799-869 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Gastroenterology ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Subject code 610
    Language English
    Publishing date 2009-04-01T00:00:00Z
    Publisher Baishideng Publishing Group Co. Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Recommendations for greater accuracy in the standard care for the detection of early Barrett's esophageal cancer.

    Hookman, Perry / Barkin, Jamie S

    The American journal of gastroenterology

    2002  Volume 97, Issue 5, Page(s) 1246–1249

    Language English
    Publishing date 2002-05
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.1111/j.1572-0241.2002.05676.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach.

    Hookman, Perry / Barkin, Jamie S

    The American journal of gastroenterology

    2003  Volume 98, Issue 2, Page(s) 495–499

    MeSH term(s) Animals ; Fatty Liver/drug therapy ; Fatty Liver/metabolism ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Metformin/therapeutic use ; Mice ; Mice, Obese
    Chemical Substances Hypoglycemic Agents ; Metformin (9100L32L2N)
    Language English
    Publishing date 2003-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.1111/j.1572-0241.2003.07276.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: What should be the standard care for cancer surveillance, diagnosis of dysplasia, and the decision for colectomy in chronic inflammatory bowel disease?

    Hookman, Perry / Barkin, Jamie S

    The American journal of gastroenterology

    2002  Volume 97, Issue 5, Page(s) 1249–1255

    Language English
    Publishing date 2002-05
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.1111/j.1572-0241.2002.05678.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top